A vaccine against the colorectal cancer pathogen, Fusobacterium nucleatum Development of a Fusobacterium nucleatum polysaccharide-based vaccine Anti-diarrhea vaccine (anti-Campylobacter jejuni) Design of Campylobacter jejuni vaccine Review of Campylobacter polysaccharide vaccines Research publication about anti-diarrhea vaccine News article Clostridium difficile vaccine Book chapter describing the synthesis of a Clostridium difficile vaccine Vaccination with Clostridium difficile PS-II polysaccharide antigen induced protection in mice Review about Clostridium difficile carbohydrate-based vaccines Discovery of Clostridium difficile capsule polysaccharides PS-I and PS-II Patent divulging water-soluble polysaccharides (PS-I and PS-II) and phenol-soluble polysaccharide (PS-III) of Clostridium difficile Discovery of glucan in Clostridium difficile spores and immunogenicity of PS-II Synthesis and immunogenicity of Clostridium difficile PS-II conjugate vaccines Synthesis of the repeating unit of Clostridium difficile polysaccharide PS-I and detection of PS-I antibodies Development of diagnostics to detect autism-associated gut bacteria Key points and goals Discovery of Clostridium bolteae immunogenic polysaccharide Gut bacteria may hold key to some autism-related symptoms A vaccine target for Clostridium bolteae, an autism-associated bacterium Gastric cancer vaccine (anti-Helicobacter pylori) Document iconOpen accn_helicobacter_pylori_news.pdf graphic excerpt from ACCN article Using some clever polysaccharide chemistry, researchers at the University of Guelph have created a conjugate that could lead to the world's first vaccine against the notorious bacterium Heliobacter pylori